Thursday, July 3, 2025

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the Nasdaq Global Market today under the symbol “CADL”. The firm’s initial public offering is looking to raise US$72.0 million and is expected to close on July 29, 2021.

The offering will be conducted through the issuance of 9,000,000 common shares selling at US$8.00 per share. This is an adjustment from the company’s original plan to issue 6.1 million shares with share price expectations between US$13.00 and US$15.00.

The company granted a 30-day over-allotment option to purchase additional 1,350,000 common shares at the same IPO price, potentially bringing proceeds up to US$82.8 million. Jefferies, Credit Suisse, BMO Capital Markets, and UBS Investment Bank are all acting as joint bookrunners for the said offering.

The Massachusetts-based biotech firm is in the business of developing novel oncolytic viral immunotherapies to treat patients with cancer, inducing “immunogenic cell death in cancer cells at the site of injection”. Currently, Candel Therapeutics has immunotherapy platforms in its portfolio –the lead adenovirus platform product candidate CAN-2409 and the lead HSV platform product candidate CAN-3310.


Information for this briefing was found via Sedar and Candel Therapeutics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Singapore-Based SPAC RF Acquisition Prices US$100 Million IPO

Special purpose acquisition company RF Acquisition Corp. (Nasdaq: RFACU) started trading its securities on the...

Thursday, March 24, 2022, 02:25:00 PM

Chinese Fund-Backed Marine SPAC Blue World Acquisition Prices US$80 Million IPO

Special purpose acquisition company Blue World Acquisition Corporation (Nasdaq: BWAQU) started trading publicly on the...

Tuesday, February 1, 2022, 02:28:00 PM

Ex-Wipro CEO-led SPAC Compass Digital Acquisition Prices US$200 Million IPO

Special purpose acquisition company Compass Digital Acquisition Corp. (Nasdaq: CDAQU) started trading publicly on the...

Friday, October 15, 2021, 02:27:00 PM

Agritech Firm AgriFORCE Seeks To Raise US$13.6 Million In Its IPO

Agriculture-focused technology company AgriFORCE Growing Systems Ltd. goes public today on the Nasdaq Capital Market....

Thursday, July 8, 2021, 10:21:00 AM

Ex-Sony Entertainment CEO-Led Gaming SPAC PowerUp Acquisition Prices Upsized US$250 Million IPO

Special purpose acquisition company PowerUp Acquisition Corp (Nasdaq: PWUPU) started trading publicly on the Nasdaq...

Friday, February 18, 2022, 02:26:00 PM